XTL BIOPHARMACEUTICALS LTD | CIK:0001023549 | 3

  • Filed: 3/15/2018
  • Entity registrant name: XTL BIOPHARMACEUTICALS LTD (CIK: 0001023549)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/0001213900-18-003028-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/xtlb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001023549
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory

    NOTE 23: EVENTS AFTER THE REPORTING DATE

     

    On February 1, 2018 the Company filed an amendment to its F-1 to register for resale (i) ordinary shares underlying warrants issued in the Company’s February 2017 private placement and (ii) ordinary shares issued and ordinary shares underlying warrants issued in the Company’s March 2017 private placement. The F-1 was declared effective on March 6, 2018.